| ICC | CIN 2/3 | ||
---|---|---|---|---|
 | n | Prevalence (95% CI) | n | Prevalence (95% CI) |
Total tested | 114 | -- | 75 | -- |
Total with valid resultsa | 100 | -- | 69 | -- |
  Positive for any HPVb | 93 | -- | 65 | -- |
  HPV-16 positive | 48 | 51.6% (41.6–61.5) | 36 | 55.4% (43.3–66.8) |
  HPV-18 positive | 23 | 24.7% (17.1–34.4) | 5 | 7.7% (3.3–16.8) |
  Other HR HPV positive | 38 | 40.9% (31.4–51.0) | 43 | 66.2% (54.0–76.5) |
HPV-16 and/or HPV-18 positive | 65 | 69.9% (59.9–78.3) | 38 | 58.5% (46.3–69.6) |